Bastide Le Confort Médical Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Vincent Bastide
Chief executive officer
€264.8k
Total compensation
| CEO salary percentage | 75.5% |
| CEO tenure | 27yrs |
| CEO ownership | 1.5% |
| Management average tenure | no data |
| Board average tenure | 3.4yrs |
Recent management updates
Recent updates
Investors Appear Satisfied With Bastide Le Confort Médical SA's (EPA:BLC) Prospects As Shares Rocket 28%
Dec 12
Bastide Le Confort Médical's (EPA:BLC) Soft Earnings Don't Show The Whole Picture
Nov 13Bastide Le Confort Médical SA (EPA:BLC) Just Reported, And Analysts Assigned A €28.17 Price Target
Oct 26We Like These Underlying Return On Capital Trends At Bastide Le Confort Médical (EPA:BLC)
Jun 14Bastide Le Confort Médical (EPA:BLC) Has A Somewhat Strained Balance Sheet
May 27Why Investors Shouldn't Be Surprised By Bastide Le Confort Médical SA's (EPA:BLC) 28% Share Price Surge
May 12Is Now An Opportune Moment To Examine Bastide Le Confort Médical SA (EPA:BLC)?
Apr 27Investors Can Find Comfort In Bastide Le Confort Médical's (EPA:BLC) Earnings Quality
Apr 06Benign Growth For Bastide Le Confort Médical SA (EPA:BLC) Underpins Stock's 26% Plummet
Mar 28Positive Sentiment Still Eludes Bastide Le Confort Médical SA (EPA:BLC) Following 28% Share Price Slump
Feb 08The Return Trends At Bastide Le Confort Médical (EPA:BLC) Look Promising
Nov 18What Is Bastide Le Confort Médical SA's (EPA:BLC) Share Price Doing?
May 17Bastide Le Confort Médical (EPA:BLC) Is Doing The Right Things To Multiply Its Share Price
Jan 27Is Bastide Le Confort Médical SA (EPA:BLC) Potentially Undervalued?
Nov 22Bastide Le Confort Médical (EPA:BLC) Is Reinvesting At Lower Rates Of Return
Sep 21Is It Time To Consider Buying Bastide Le Confort Médical SA (EPA:BLC)?
Jul 28When Should You Buy Bastide Le Confort Médical SA (EPA:BLC)?
Mar 18Be Wary Of Bastide Le Confort Médical (EPA:BLC) And Its Returns On Capital
May 16Here's Why Bastide Le Confort Médical (EPA:BLC) Has A Meaningful Debt Burden
Apr 30We Think Bastide Le Confort Médical's (EPA:BLC) Profit Is Only A Baseline For What They Can Achieve
Apr 07Should You Think About Buying Bastide Le Confort Médical SA (EPA:BLC) Now?
Mar 10Is Bastide Le Confort Médical SA's (EPA:BLC) 16% ROE Better Than Average?
Feb 21Bastide Le Confort Médical SA's (EPA:BLC) Intrinsic Value Is Potentially 33% Above Its Share Price
Feb 07
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | €265k | €200k | €7m |
| Mar 31 2024 | n/a | n/a | €7m |
| Dec 31 2023 | n/a | n/a | €6m |
| Sep 30 2023 | n/a | n/a | €11m |
| Jun 30 2023 | €302k | €200k | €16m |
| Dec 31 2022 | n/a | n/a | €18m |
| Sep 30 2022 | n/a | n/a | €16m |
| Jun 30 2022 | €180k | €150k | €14m |
| Dec 31 2021 | n/a | n/a | €13m |
| Sep 30 2021 | n/a | n/a | €13m |
| Jun 30 2021 | €57k | €49k | €13m |
Compensation vs Market: Vincent's total compensation ($USD276.10K) is below average for companies of similar size in the French market ($USD430.67K).
Compensation vs Earnings: Vincent's compensation has been consistent with company performance over the past year.
CEO
Vincent Bastide
27yrs
Tenure
€264,804
Compensation
Mr. Vincent Bastide serves as Director of Bastide Le Confort M dical SA and serves as its Chairman & Chief Executive Officer. He previously served as the Chief Executive Officer at Bastide Le Confort Mdic...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 27yrs | €264.80k | 1.52% € 2.7m | |
| Independent Director | 5.4yrs | €27.50k | no data | |
| Independent Director | 3.4yrs | €35.00k | no data | |
| Employee Representative Director | 3.2yrs | €28.95k | no data | |
| Independent Director | 3.4yrs | €35.00k | no data | |
| Independent Director | 3.4yrs | €30.00k | no data |
3.4yrs
Average Tenure
Experienced Board: BLC's board of directors are considered experienced (3.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/27 03:23 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Bastide Le Confort Médical SA is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robin Leclerc | Degroof Petercam |
| Guillaume Cuvillier | Gilbert Dupont |
| Murielle Andre-Pinard | HSBC |